(DAILYMAIL) — Regulators yesterday approved the first therapy in the western world that can correct errors in a person’s genetic code.
Europe has approved Glybera to be used against a rare inherited disorder which disrupts fat production in the body.
The treatment uses a virus to counteract LPLD, lipoprotein lipase deficiency, which can led to acute inflammation of the pancreas.
Advertisement - story continues below
The illness affects around one or two people per million and sufferers have damaged copies of a gene which is essential for breaking down fats. The virus infects muscle cells with a copy of a healthy gene and a one-off treatment is effective.